Television presenter Lisa Wilkinson has filed her defence to a defamation suit by accused rapist Bruce Lehrmann, arguing the claim that he raped fellow Liberal staffer Brittany Higgins in Parliament House in 2019 is substantially true.
A Sydney-based law firm and one if its senior partners has defeated lawsuits by five former clients alleging breach of duties and conflict of interest relating to a rejected $4.45 million settlement in an employment case against Westpac.
Snack food company Intersnack Australia has hit AIG Insurance with a lawsuit, claiming the insurer wrongly refused to cover $3 million in losses caused by an employee who allegedly gave out unauthorised discounts.
An IT specialist who claims he was was “heavily medicated” when settling Fair Work Commission claims has lost a bid to amend his pleadings in a workplace injury and negligence case that has ensnared law firms Harmers Workplace Lawyers and Firths.
Investment house Washington H. Soul Pattinson is fighting a ruling that it owes its former finance director over $1.1 million in damages after the ASX 100-listed firm terminated the executive without notice and failed to pay out entitlements.
Payouts in class actions in 2020 largely kept pace with the previous year despite the financial strain of the COVID-19 pandemic, with companies and other defendants paying more than $696 million to settle class actions last year.
Shock jock Alan Jones has reached a settlement in his defamation lawsuit against SBS and The Feed presenter Alex Lee over a television segment that referred to him as someone who “spoke to the fears of every xenophobe and misogynist in the country”.
Conservative talkback host Alan Jones has filed a defamation suit against public broadcaster SBS over a “tribute” aired on ‘The Feed’ which labelled him as someone who “spoke to the fears of every xenophobe and misogynist in the country”.
A judge has approved a $7 million settlement in a class action against the directors of pharmaceutical company QRxPharma, only a third of which will go to group members, saying proportionality was not a basis for rejecting fees that were otherwise fair and reasonable.
The funder backing a shareholder class action against the directors of pharmaceutical firm QRxPharma will not seek to profit from a $7 million settlement in order to bring about a better return for group members, a judge has been told.